| |
|
2006
|
|
Top
|
|
Vol. 5
|
|
December December 2006 No. 20, p989
|
|
Medical Therapy for BPH:What Factors Should We Consider?
|
|
November November 2006 No. 19, p911
|
|
UroLap 2005 Second International Urologic Workshop in Laparoscopy
|
|
November November 2006 No. 18, p887
|
|
Improving Management of Prostate Cancer: Are all LHRH Agonists Equal? Proceedings of the EAU 2006 symposium, 7 April 2006, Paris
|
|
October October 2006 No. 17, p871
|
|
Skeletal Preservation in Prostate Cancer: The Changing Role of the Urologist
|
|
October October 2006 No. 16, p835
|
|
Perspectives on Mixed Incontinence
|
|
September September 2006 No. 15, p811
|
|
Prostate Cancer: Optimising Treatment Strategy to Meet Our Patients' Needs. European Association of Urology (EAU) Annual Congress, Paris, 5–8 April 2006
|
|
September September 2006 No. 14, p787
|
|
Abstracts of the 17th Meeting of the European Society for Urological Research (ESUR)
|
|
September September 2006 No. 13, p759
|
|
Erectile Dysfunction and Sexual Satisfaction: New Perspectives
|
|
August August 2006 No. 12, p697
|
|
Examining the Forefront of Research and Clinical Practice in Prostate Disease. Prostate Health Forum - Today's Advances, Tomorrow's Clinical Practice. Vienna, Austria: October 14–15 2005
|
|
July July 2006 No. 11, p667
|
|
Botulinum Toxin in the Overactive Bladder: From Theory to Therapy Based on 'Botulinum Toxin in the Overactive ladder', an International Continence Society workshop, Montreal, 29 August 2005
|
|
July July 2006 No. 10, p647
|
|
An Integrated Approach to Preventing Progression in Superficial Bladder Cancer: Prognostic Factors, Optimal Treatment Regimens, and Side-Effect Management A Satellite Symposium of the 5th Annual Perspectives in Bladder Cancer
|
|
June June 2006 No. 9, p627
|
|
The Role of Finasteride in the Management of BPH and in the Prevention of Prostate Cancer
|
|
June June 2006 No. 8, p557
|
|
"Recitatio Artis Plena" on Kidney Cancer
|
|
April April 2006 No. 7, p537
|
|
Management of Prostate Cancer: Why is the Urologist's Role Changing? XXth European Association of Urology 2005 Symposium, 17 March 2005, Istanbul, Turkey
|
|
April April 2006 No. 6, p471
|
|
Technical Aspects of Urooncological Interventions Third Fall Meeting of the European Society of Oncological Urology (ESOU), 13-15 January 2006, Brussels, Belgium
|
|
April April 2006 No. 5, p441
|
|
Circumcaval Ureter: 2006 Update Celebrating the 20th Anniversary of the Department of Urology, Università Vita-Salute San Raffaele, Milan, Italy
|
|
April April 2006 No. 4, p399
|
|
New Insights in the Pathophysiology and Drug Management of Lower Urinary Symptoms Due to Benign Prostatic Enlargement: The Role of PermixonTM
|
|
April April 2006 No. 3, p359
|
|
Advances in Prostate and Bladder Cancer Management Proceedings from the symposium "New Horizons in Urology", Malta, 29-30 October, 2005
|
|
April April 2006 No. 2, p23
|
|
January January 2006 No. 1, p1
|
|
Expert Opinion on Hours of Undisturbed Sleep (HUS): A new tool to evaluate the impact of nocturia on LUTS/BPH patients
|
|
|
2005
|
|
Top
|
|
Vol. 4
|
|
November November 2005 No. 8, p1
|
|
Expert Report on Optimising Hormonal Control in Prostate Cancer
|
|
October October 2005 No. 7, p1
|
|
Omnic OCAS®: Proceedings of the European Launch Symposium, Reykjavik, Iceland, 11 February 2005
|
|
August August 2005 No. 6, p1
|
|
Would you recognize LOH if it walked into your practice? Diagnosis and management of late-onset hypogonadism
|
|
July July 2005 No. 5, p1
|
|
Prostate Cancer: Testosterone Suppression Levels and Eligard®
|
|
March March 2005 No. 4, p1
|
|
Controversies in the Management of Bladder Cancer and Prostate Cancer
|
|
March March 2005 No. 3, p3
|
|
XXth Congress of the European Association of Urology
|
|
February February 2005 No. 2, p1
|
|
OCAS: The Evolution of Tamsulosin for the Treatment of LUTS/BPH
|
|
January January 2005 No. 1, p1
|
|
Management of stress urinary incontinence in women: challenges and new perspectives
|
|
|
|
2004
|
|
Top
|
|
Vol. 3
|
|
November November 2004 No. 5, p1
|
|
Bone Complications in Prostate Cancer: The Clinical Role of Zoledronic Acid
|
|
September September 2004 No. 4, p1
|
|
Integrating Patient Risk Profiles: The Future Management of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
|
|
March March 2004 No. 3, p1
|
|
Urological Malignancies: From Diagnosis to Treatment. First Fall Meeting of the European Society of Oncological Urology (ESOU)
|
|
February February 2004 No. 2, p1
|
|
XIXth Congress of the European Association of Urology
|
|
February February 2004 No. 1, p1
|
|
Hormonal Management of Prostate Cancer: Current Status and Future Developments
|
|
|
2003
|
|
Top
|
|
Vol. 2
|
|
December December 2003 No. 10, p1
|
|
Sexuality: A Vital Aspect for the BPH Patient. Satellite Symposium held during the XVIIIth Congress of the EAU
|
|
December December 2003 No. 9, p1
|
|
Prostate Cancer Treatment on Trial
|
|
November November 2003 No. 8, p1
|
|
Facing the Challenges of BPH Management. Satellite symposia held during the XVIIth and XVIIIth Congresses of the EAU
|
|
November November 2003 No. 7, p1
|
|
Managing Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH): The Total Approach
|
|
September 24 September 2003 No. 6, p1
|
|
September September 2003 No. 5, p1
|
|
Overactive Bladder: Reviewing the Evidence
|
|
September September 2003 No. 4, p1
|
|
New Aspects in the Treatment of Interstitial Cystitis
|
|
March March 2003 No. 3, p1
|
|
Revolutions in the Management of Hormone-Refractory Prostate Cancer
|
|
March March 2003 No. 2, p1
|
|
International Consensus Conference on Advances in the Diagnosis and Treatment of Prostatitis
|
|
February February 2003 No. 1, p1
|
|
XVIIIth Congress of the European Association of Urology
|
|
|
2002
|
|
Top
|
|
Vol. 1
|
|
December December 2002 No. 10, p1
|
|
The Use of Biomaterials in Urology (Satellite Symp. of XVIIth Congr. EAU, February 23, 2002, Birmingham, UK) and Female Urology, New Understanding, New Approaches, New Materials (Satellite Symp. of XIth European Urological Winter Forum)
|
|
November November 2002 No. 9, p1
|
|
Lower Urinary Tract Symptoms: The Paradigm Shift. New Perspectives in Aetiology and Outcome. Proceedings of a Satellite Symposium held at the XVIIth Congress of the EAU, February 25, 2002, Birmingham, UK
|
|
November November 2002 No. 8, p1
|
|
Advances in the Treatment of Erectile Dysfunction, XVIIth Congress of the EAU, February 23, 2002, Birmingham, UK
|
|
October October 2002 No. 7, p1
|
|
Prostate Cancer - Life after Diagnosis, 29-30 November 2001, Nice, France
|
|
September September 2002 No. 6, p1
|
|
Transrectal Ultrasound Prostatic Biopsy in the PSA Era
|
|
August August 2002 No. 5, p1
|
|
PSA Change Predicts Survival - Fact or Fiction? EAU, February 24, 2002, Birmingham, UK
|
|
July July 2002 No. 4, p1
|
|
Overactive Bladder: New Perspectives
|
|
May May 2002 No. 3, p1
|
|
The Evolution of Apomorphine SL in the Management of Erectile Dysfunction (ED)
|
|
May May 2002 No. 2, p1
|
|
January January 2002 No. 1, p3
|
|
| |
|
